1. Stocks
  2. Concord Biotech Ltd.
  3. Swot
swot-logo

Concord Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Concord Biotech Ltd. has 22 Strengths, 5 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Best results last week in YoY net profit and revenue growth

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Expensive Performers (DVM)

Stocks gaining versus previous close, open price and RSI

Good quarterly growth in the recent results

Results in the last two days with YoY and QoQ Net Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Companies with Zero Promoter Pledge

RSI indicating price strength

High Volume, High Gain

MACD crossed above zero line previous end of day

Top Gainers

High Volume, High Gain

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

US FDA Warning Letter

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks